Form 4 for IRON Disc Medicine, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0000950170-25-013714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-02-04 | 2025-02-03 | IRON | Khara Rahul | CLO | M - OptEx | $14.69 | +7,500 | 21.5K | +53% | +$110.2K |
| DMT | 2025-02-04 | 2025-02-03 | IRON | Khara Rahul | CLO | S - Sale+OE | $55.55 | -7,500 | 14.0K | -35% | -$416.6K |
| DT | 2025-02-04 | 2025-02-03 | IRON | Khara Rahul | CLO | M - OptEx | $0.00 | -7,500 | 64.8K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 7,500 | $14.69 | 21,535 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 5,687 | $55.40 | 15,848 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.87 to $55.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
| 3 | Common | Common Stock | 2025-02-03 | S | D | 1,813 | $56.01 | 14,035 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.28, inclusive. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 7,500 | $0.00 | 64,804 | D | $14.69 · — to 2032-02-06 | 7,500 Common Stock | (F4) 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |